Proximity labeling, quantitative proteomics, and biochemical studies revealed the molecular mechanism for the Inhibitory Effect of Indisulam on the proliferation of gastric Cancer cells
Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes a Danish nationwide observational study
Oral KPV will not achieve the plasma concentrations required for systemic tissue effectsswitch to injectable
Body Composition Research Applications Laboratory studies investigate Ipamorelin in body composition research: Fat Mass Regulation Studies: Research on GH-mediated lipolysis, adipose tissue reduction, and fat distribution changes Lean Mass Investigation: Studies examining muscle protein synthesis, nitrogen retention, and muscle mass changes IGF-1 Mediated Effects: Research on growth factor pathway activation downstream of GH elevation Body Composition Remodeling: Investigation of simultaneous fat loss and lean mass preservation or gain Regional Fat Distribution: Studies examining visceral versus subcutaneous adipose tissue responses Experimental models include body composition assessment in animal studies examining changes over multiple weeks of Ipamorelin administration
Tania Dempsey: Yeah, so, great questions
This initiative is timely: the global market for GLP-1 obesity and diabetes drugs is exploding (projected ~USD 62 billion in 2025 to ~USD 157 billion by 2035 ( [7] ), with forecasts of ~$200 billion by 2030 ( [8] ) and tens of millions of patients on GLP-1s by the end of the decade)